Evaluation of PCL rapid point of care antigen test for detection of SARS‐CoV‐2 in nasopharyngeal swabs

[1]  G. Lippi,et al.  Updates on laboratory investigations in coronavirus disease 2019 (COVID-19) , 2020, Acta bio-medica : Atenei Parmensis.

[2]  Georgia Salanti,et al.  Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis , 2020, medRxiv.

[3]  M. Mochón,et al.  Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection , 2020, Journal of Clinical Virology.

[4]  Gannon C.K. Mak,et al.  Evaluation of rapid antigen test for detection of SARS-CoV-2 virus , 2020, Journal of Clinical Virology.

[5]  M. Tré-Hardy,et al.  Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospital , 2020, Journal of Clinical Virology.

[6]  M. Van Ranst,et al.  Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients , 2020, Clinical Microbiology and Infection.

[7]  Hector Rodriguez-Villalobos,et al.  Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis , 2020, Journal of Clinical Virology.

[8]  C. Delaugerre,et al.  Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs , 2020, Journal of Clinical Microbiology.

[9]  T. Jin,et al.  Characteristics of patients with coronavirus disease (COVID‐19) confirmed using an IgM‐IgG antibody test , 2020, Journal of medical virology.

[10]  W. Organization.  Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays , 2020 .